◄ back to all posts

CRSP: CRISPR Therapeutics AG Stock

Written by | Jul 6, 2018
Valuation
Market Cap ($M) 3,317.54
Enterprise Value ($M) 2,995.93
Book Value ($M) 379.81
Book Value / Share 7.18
Price / Book 9.04
NCAV ($M) 331.73
NCAV / Share 6.27
Price / NCAV 9.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.88

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 15.84

Balance Sheet (mrq) ($M)
Current Assets 449.80
Assets 497.87
Liabilities 118.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.12
Operating Income -158.94
Net Income -164.98
Earnings Per Share Basic And Diluted -3.44
Earnings Per Share Diluted -3.44
Earnings Per Share Basic -3.44

Cash Flow Statement (mra) ($M)
Cash From Operations -96.24
Cash from Investing -2.77
Cash from Financing -2.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13D/A Glaxosmithkline Plc 5.50 0.92
2020-02-13 13G/A Vertex Pharmaceuticals Inc / Ma 4.40 -50.00
2020-02-12 13G Nikko Asset Management Americas, Inc. 5.08
2020-02-12 13G Sumitomo Mitsui Trust Holdings, Inc. 5.08
2020-02-04 13D/A Bayer Global Investments B.v. 4.90 -19.87
2019-06-28 13D/A Versant Venture Capital IV, L.P. 4.30 -18.17
2019-02-12 13G/A New Enterprise Associates 15, L.p.
2018-02-08 13D/A Celgene Corp /de/ 6.10 -15.30
2018-01-16 13D/A Abingworth LLP 4.00 -12.07

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-02-12 10-K CRSP / CRISPR Therapeutics AG 10-K – Annual Report – 10-K
2019-10-28 10-Q CRSP / CRISPR Therapeutics AG 10-Q – Quarterly Report – 10-Q
2019-07-29 10-Q CRSP / CRISPR Therapeutics AG 10-Q – Quarterly Report – 10-Q
2019-04-29 10-Q CRSP / CRISPR Therapeutics AG 10-Q (Quarterly Report) 10-Q
2019-02-25 10-K CRSP / CRISPR Therapeutics AG FORM 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 248,713 1,623,800 15.32
2020-02-13 566,303 2,198,000 25.76
2020-02-12 190,126 997,500 19.06
2020-02-11 273,660 1,554,600 17.60
2020-02-10 320,950 1,550,600 20.70

(click for more detail)


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
401 K